|

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

RECRUITINGN/ASponsored by Emory University
Actively Recruiting
PhaseN/A
SponsorEmory University
Started2020-03-19
Est. completion2026-05-27
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04342429

Summary

To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Pathologically confirmed small cell lung cancer, limited or extensive stage.
* Patients who are offered thoracic radiotherapy with intensity-modulated proton therapy (IMPT) techniques delivering 30-66 Gy in 15-33 fractions at 2 Gy per fraction, at the recommendation of the treating radiation oncologist.
* Age 18 or greater

Exclusion Criteria:

* Prior radiation therapy which would provide significant dose overlap with the planned target volume(s)
* Pregnancy

Conditions3

CancerLung CancerSmall Cell Lung Cancer

Locations1 site

Winship Cancer Institute
Atlanta, Georgia, 30322
Kristin Higgins, MD404-778-0603kristin.higgins@emory.edu

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.